"if it's not working, why would they be testing it?": Mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Chakrapani, Venkatesan ^a   Newman, Peter A ^b   Singhal, Neeti ^c   Nelson, Ruban ^a   Shunmugam, Murali ^a  

^a Centre for Sexuality and Health Research and Policy (C SHaRP)   (India)

^b UNIVERSITY OF TORONTO   (Canada)

^c The Humsafar Trust   (India)

Author keywords

Clinical trials; HIV vaccines; India; Informed consent; Men who have sex with men; Preventive misconception; Qualitative research; Vaccine induced seropositivity

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ANIMAL; ATTITUDE TO HEALTH; DEMOGRAPHY; HIV INFECTIONS; HUMAN; INDIA; INFORMATION PROCESSING; INTERVIEW; MALE; MALE HOMOSEXUALITY; MEDICAL RESEARCH; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; SOCIAL STIGMA; YOUNG ADULT;

ADULT; AIDS VACCINES; ANIMALS; BIOMEDICAL RESEARCH; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INDIA; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; SOCIAL STIGMA; YOUNG ADULT;

EID: 84881050961     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-731     Document Type: Article

References (52)

1. Therapeutic misconception and the appreciation of risks in clinical trials. Lidz CW, Appelbaum PS, Grisso T, Renaud M, Soc Sci Med 1982 58 1689 1697
2. HIV vaccine trials: critical issues in informed consent. Lindegger G, Richter LM, S Afr J Sci 2000 96 313 317 15739286
3. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach. Chakrapani V, Newman PA, Singhal N, Jerajani J, Shunmugam M, PLoS One 2012 7 12 51080 10.1371/journal.pone.0051080 23226560
4. Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. Lindegger G, Milford C, Slack C, Quayle M, Xaba X, Vardas E, J Acquir Immune Defic Syndr 2007 43 5 560 566 (Pubitemid 44885623)
5. Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible? Excler JL, Beyrer C, J Hum Virol 2000 3 193 214 10990167
6. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). Guenter D, Esparza J, Macklin R, J Med Ethics 2000 26 37 43 10.1136/jme.26.1.37 10701170 (Pubitemid 30119747)
7. Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. Lurie P, Bishaw M, Chesney MA, Cooke M, Fernandes ME, Hearst N, Katongole-Mbidde E, Koetsawang S, Lindan CP, Mandel J, Mhloyi M, Coates TJ, JAMA 1994 271 4 295 301 10.1001/jama.1994.03510280057033 8295289 (Pubitemid 24030757)
8. UNAIDS, Global Report: UNAIDS Report on the Global AIDS Epidemic 2010 Geneva 2010 http://www.unaids.org/globalreport/global-report.htm
9. Preparedness for AIDS vaccine trials in India. Excler JL, Kochhar S, Kapoor S, Das S, Bahri J, Ghosh MD, Ganguly NK, Nayyar A, Chataway M, Indian J Med Res 2008 127 6 531 538 18765870
10. Research halted at Indian centre accused of misconduct. Sharma DC, Lancet 2001 358 9286 992 11583767
11. Medical research in India. Thorat MA, Lancet 2006 368 9536 643 644 16920462 (Pubitemid 44223683)
12. AIDS vaccine trials in India: ethical benchmarks and unanswered questions. Jesani A, Coutinho L, Indian J Med Ethics 2007 4 2 3 18630210
13. AIDS vaccine trials for India: getting the facts right. Nayyar A, Indian J Med Ethics 2007 4 109 110 18624135
14. India stops further trials of HIV vaccine. Padma TV, Science and Development Network 2007 http://webcache.googleusercontent.com/search?q=cache: bXNeT7BygfQJ:www.scidev.net/fr/news/l-inde-met-un-terme-aux-essais-d-un-vaccin- contre-.html%3Fscimob%3D1+&cd=1&hl=en&ct=clnk&gl=th
15. Deconstructing social resistance to pulse polio campaign in two North Indian districts. Chaturvedi S, Dasgupta R, Adhish V, Ganguly KK, Rai S, Sushant L, Srabasti S, Arora NK, Indian Pediatr 2009 46 11 963 974 19736365
16. Fatigue and fear with shifting polio eradication strategies in India: a study of social resistance to vaccination. Hussain RS, McGarvey ST, Shahab T, Fruzzetti LM, PLoS One 2012 7 9 46274 10.1371/journal.pone.0046274 23050003
17. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. Mattheij I, Pollock AM, Brhlikova P, J R Soc Med 2012 105 6 250 262 10.1258/jrsm.2012.110343 22722970
18. HPV vaccination: waiting for evidence of effectiveness. Suba EJ, Raab SS, Lancet 2010 375 9715 639 640 20171401
19. Row erupts over study of HPV vaccine in 23,000 girls in India. Mudur G, BMJ 2012 345 4390 10.1136/bmj.e4390 22750470
20. Pandey V, Cancer vaccine programme suspended after 4 girls die [ http://www.dnaindia.com/india/report-cancer-vaccine-programme-suspended-after-4- girls-die-1368681 ]
21. Dhar A, Centre halts HPV vaccine project [ http://www.hindu.com/2010/04/ 08/stories/2010040857390100.htm ]
22. The cervical cancer bazaar. Ray SG, Majumdar K, Tehelka Magazine 2010 7 11 http://archive.tehelka.com/story-main44.asp?filename=Ne200310coverstory.asp
23. Decriminalising homosexuality in India. Misra G, Reprod Health Matters 2009 17 34 20 28 10.1016/S0968-8080(09)34478-X 19962634
24. HIV in Indian MSM: reasons for a concentrated epidemic & strategies for prevention. Thomas B, Mimiaga MJ, Kumar S, Swaminathan S, Safren SA, Mayer KH, Indian J Med Res 2011 134 6 920 929 10.4103/0971-5916.92637 22310824
25. Mental models and human reasoning. Johnson-Laird PN, Proc Natl Acad Sci 2010 107 43 18243 18250 10.1073/pnas.1012933107 20956326
26. Morgan MG, Fischhoff B, Bostrom A, Atman CJ, Risk Communication: A Mental Models Approach New York: Cambridge University Press 2002
27. A small dose of HIV? HIV vaccine mental models and risk communication. Newman PA, Seiden DS, Roberts KJ, Kakinami L, Duan N, Health Educ Behav 2009 36 2 321 333 18032589
28. Mental models in human-environment interactions: theory, policy implications, and methodological explorations. Lynam T, Brown K, Ecol Soc 2011 17 3 24
29. Vaccine risk communication: lessons from risk perception, decision-making and environmental risk communication. Bostrom A, Risk Health Saf Environ 1997 8 173 200
30. Parents' vaccination comprehension and decisions. Downs JS, Bruine de Bruin W, Fischhoff W, Vaccine 2008 26 1595 1607 10.1016/j.vaccine.2008.01.011 18295940
31. "Once bitten, twice shy": participant perspectives in the aftermath of an early HIV vaccine trial termination. Newman PA, Yim S, Daley A, Walisser R, Halpenny R, Cunningham W, Loutfy M, Vaccine 2011 29 3 451 458 10.1016/j.vaccine.2010.10.076 21075163
32. Community-based participatory research from the margin to the mainstream: are researchers prepared? Horowitz CR, Robinson M, Seifer S, Circulation 2009 119 19 2633 2642 10.1161/CIRCULATIONAHA.107.729863 19451365
33. Patton MQ, Qualitative Research and Evaluation Methods Thousand Oaks: Sage Publications 2002
34. Guest G, MacQueen KM, Namey EE, Applied Thematic Analysis Thousand Oaks: Sage Publications 2012
35. Charmaz K, Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis Thousand Oaks: Sage Publications 2006
36. Lincoln YS, Guba EG, Naturalistic Inquiry Newbury Park: Sage Publications 1985
37. Preventive misconception: its nature, presence, and ethical implications for research. Simon AE, Wu AW, Lavori PW, Sugarman J, Am J Prev Med 2007 32 5 370 374 10.1016/j.amepre.2007.01.007 17478261 (Pubitemid 46660442)
38. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? Sekaly RP, J Exp Med 2008 205 1 7 12 10.1084/jem.20072681 18195078 (Pubitemid 351185709)
39. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN, the Step Study Protocol Team, Lancet 2008 372 1881 1893 10.1016/S0140-6736(08)61591-3 19012954
40. Norm theory: comparing reality to its alternatives. Kahneman D, Miller DT, Psychol Rev 1986 93 136 153
41. Choices, values, and frames. Kahneman D, Tversky A, Am Psychol 1984 39 341 350
42. Community heroes or 'high-risk' pariahs? Reasons for declining to enroll in an HIV vaccine trial. Newman PA, Daley A, Halpenny R, Loutfy M, Vaccine 2008 26 8 1091 1097 10.1016/j.vaccine.2007.12.016 18237829
43. Adapting the minority stress model: associations between gender non-conformity stigma, HIV-related stigma and depression among men who have sex with men in South India. Logie CH, Newman PA, Chakrapani V, Shunmugam M, Soc Sci Med 2012 74 8 1261 1268 10.1016/j.socscimed.2012.01.008 22401646
44. 'Speaking the dialect': understanding public discourse in the aftermath of an HIV vaccine trial shutdown. Newman PA, Logie C, James L, Charles T, Maxwell J, Salam K, Woodford M, Am J Public Health 2011 101 9 1749 1758 21778490
45. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E, J Acquir Immune Defic Syndr 2004 36 1 604 612 10.1097/00126334-200405010-00009 15097304 (Pubitemid 38544510)
46. Undue inducement in clinical research in developing countries: is it a worry? Emanuel EJ, Currie XE, Herman A, Lancet 2005 366 336 340 10.1016/S0140-6736(05)66992-9 16039339 (Pubitemid 41019426)
47. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, Hoffman I, AIDS Behav 2012 16 3 785 790 10.1007/s10461-011-0027-7 21863339
48. HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD, VISION/VAX004 Study Team, J Acquir Immune Defic Syndr 2005 39 90 101 10.1097/01.qai.0000143600.41363.78 15851919 (Pubitemid 40617024)
49. Interventions to improve research participants' understanding in informed consent for research: a systematic review. Flory J, Emanuel EJ, JAMA 2004 292 1593 1601 10.1001/jama.292.13.1593 15467062 (Pubitemid 39314966)
50. Ambiguities of 'culture' and the antiretroviral rollout in South Africa. Ashforth A, Nattrass N, Soc Dyn 2005 31 2 285 303 10.1080/02533950508628716 (Pubitemid 44110261)
51. 'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials. Koen J, Essack Z, Slack C, Lindegger G, Newman PA, Dev World Bioeth Epub ahead of print. 10.1111/j.1471-8847.2012.00338.x/abstract
52. Towards a science of community engagement. Newman PA, Lancet 2006 367 9507 302 16443036